Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.

Effortlessly conduct multi-center clinical trials worldwide for drug development with Castor’s EDC and CDMS platforms, including eCOA, ePRO, EHR eSource, eConsent, and IRT modules.

Regulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.

Effortlessly conduct multi-center clinical trials worldwide for drug development with Castor’s EDC and CDMS platforms, including eCOA, ePRO, EHR eSource, eConsent, and IRT modules.

Discover how the solution to the "Re-Consent" problem in clinical trials is an infrastructure that enables real-time continuous monitoring and eliminates the need for secondary data entry, and hence, source data verification.

Castor’s suite of modular eConsent solutions creates clinical trial efficiencies from recruitment and screening, all the way to direct data capture and analysis. 

With a combination of technology and consultative support from team experts, start experiencing a seamless ePRO transition and establish a smoother path to regulatory submission today.

Dive into the ways this cutting-edge technology is revolutionizing how healthcare providers create personalized treatment plans for patients suffering from chronic low back pain (CLBP).

As the volume and variety of clinical trial data have exploded - including electronic health records (EHR), sensors, and ePRO data - processes to manage and monitor that data have not kept pace. These processes are still grounded in a retroactive data review and reconciliation with a primary focus on eCRF data.